New Medical Director for LEO Pharma
Amit Aggarwal joins the medical dermatology leader
July 23 2020, Hurley, Berks, UK
LEO Pharma UK/Ireland, the leading medical dermatology company, has appointed Dr Amit Aggarwal to take the helm of its Medical Affairs team.
Amit Aggarwal has over 12 years’ experience in the pharmaceutical industry most recently at Bayer where he held various roles, latterly as Director of Medical Affairs UK, General Medicine. Prior to that he spent 5 years working clinically in the NHS, mainly in secondary care roles.
Having worked on product launches, spanning a range of therapy areas including oncology, women's health and cardiovascular medicine in the UK, and globally, as far afield as China and Russia, Amit Aggarwal brings a wealth of medical affairs and pharmacovigilance experience to the dermatology specialists LEO Pharma. He has led large teams including a STEM recognised industry-leading MSL team and driven programmes addressing unmet medical needs that led to changes in national guidelines.
In his new role at LEO Pharma Amit will lead the Medical Division including Medical Affairs, Pharmacovigilance, Quality & Compliance within the UK/Ireland affiliate, ensuring appropriate support for all operations and LEO Pharma products. As a part of the Cluster Leadership Team he will have a key leadership role across the cluster including the Nordics and ANZ affiliates.
Describing his reasons for joining the company Amit commented, “I am delighted to have joined LEO Pharma at what is an exciting and pivotal time for the company, with the opportunity to play a key part in shaping the future of the organization. When talking about LEO Pharma with industry colleagues, I was always struck by the warmth with which the company is regarded, with most knowing someone who works or who has worked at LEO Pharma, and what a great experience they have had. My first few weeks in role have certainly borne out that sentiment. I can genuinely say that it is a privilege to be working with some incredible talent here at LEO Pharma, all individuals working as a coherent collective for the betterment of patient care and outcomes in dermatology."
“I am delighted to have Amit join my leadership team to advance our Medical Division. He joins at a very exciting, transformative time for our organization as we embark on the next phase of our development bringing forward new innovative treatments and advancing the standard of care in dermatology. We have a robust dermatological pipeline, which is rapidly expanding in atopic dermatitis and rare diseases. I am sure that Amit’s extensive pharma experience across an array of primary and secondary care specialties, his real commitment to driving medical excellence in education and focus on improving patient outcomes, in line with our values, will be a great asset”, said Geraldine Murphy, Managing Director UK&IE, LEO Pharma.
UK/IE MAT-36220 July 2020
Media contact information:
About LEO Pharma
LEO Pharma helps people achieve healthy skin. By offering resources and products that help care for care solutions patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions.
Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions.
LEO Pharma is headquartered in Denmark and employs around 5,000 people worldwide. The UK/IE affiliate is headquartered in Hurley, Berkshire.
For more information about LEO Pharma UK/IE:
Follow us on Twitter: twitter.com/LEOPharmaUKIE
Subscribe to our YouTube channel: www.youtube.com/channel/UC_HWf4kPkN5Z3Po6_KfN9xw
Check out our LEO Pharma UK/IE LinkedIn Life Page: www.linkedin.com/company/leo-pharma/life/